The quest for a weight loss drug that a) works and b) doesn’t have nasty side effects is proving tricky, but new hopes rear up from time to time
Here’s the latest medicine in the spotlight: Contrave, by Orexigen Therapeutics. This week, the company announced that it had completed Phase III trial data involving several thousand patients.
In one of the trials, 48% of the patients lost more than 5% of their body weight after 56 weeks, compared with 16.4% of those taking a placebo. In another trial, the numbers were 56.3% compared with 17.1% for controls.
The amount of weight loss, on average, was 6.1% and 6.4% in the two trials, compared with 1.3% and 1.2%.
Click to read the rest of the original article as reported by The Los Angeles Times